tiprankstipranks
Trending News
More News >
Biodexa Pharmaceuticals (BDRX)
NASDAQ:BDRX
US Market

Biodexa Pharmaceuticals (BDRX) Cash flow

Compare
528 Followers

Biodexa Pharmaceuticals Cash Flow

BDRX's free cash flow for Q2 2025 was £-3.31M. For the 2025 fiscal year, BDRX's free cash flow was decreased by £-5.95M and operating cash flow was £-3.30M. See a summary of the company’s cash flow.
Cash Flow
Dec 24Dec 23Dec 22Dec 21Dec 20
Operating Cash Flow
£ -12.26M£ -6.83M£ -7.05M£ -6.01M£ -9.30M
Investing Cash Flow
£ -598.00K£ -265.00K£ -220.00K£ -278.00K£ 2.57M
Financing Cash Flow
£ 8.56M£ 10.23M£ 47.00K£ 8.80M£ 3.08M
End Cash Position
£ 1.67M£ 5.97M£ 2.84M£ 10.06M£ 7.55M
Free Cash Flow
£ -13.04M£ -7.09M£ -7.11M£ -6.33M£ -9.51M
Currency in GBP

Biodexa Pharmaceuticals Cash Flow